U.S. Stock News

NYSE:RPM
NYSE:RPMChemicals

A Look At RPM International (RPM) Valuation After Better Than Expected Q3 2026 Results And Upbeat Guidance

RPM International (RPM) drew fresh attention after reporting third quarter fiscal 2026 earnings and sales that exceeded expectations, alongside guidance regarding sales and adjusted EBIT. See our latest analysis for RPM International. The share price has eased back recently, with a 1 month share price return of 4.84% but a 90 day share price return decline of 13.30%, while the 1 year total shareholder return decline of 6.79% contrasts with a 3 year total shareholder return of 32.76%. This...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Is It Time To Reassess Phibro Animal Health (PAHC) After The Recent Share Price Pullback

Investors may be wondering if Phibro Animal Health at around US$43.16 is still offering value after a strong run, or if the easy gains are behind it. The stock has pulled back 18.8% over the last week and 22.5% over the last month, yet it still shows a 15.7% gain year to date and a 96.6% return over the past year. These sharp moves are drawing attention back to what is already priced into Phibro Animal Health and how much of its story is reflected in the current share price. Ongoing interest...
NYSE:APLE
NYSE:APLEHotel and Resort REITs

Assessing Apple Hospitality REIT (APLE) Valuation After Its Recent Share Price Momentum

Recent performance puts Apple Hospitality REIT in focus Apple Hospitality REIT (APLE) has drawn fresh attention after a one-month return of about 19% and a gain of roughly 14% over the past three months, prompting investors to reassess the hotel-focused REIT’s recent momentum. See our latest analysis for Apple Hospitality REIT. At a share price of $13.89, Apple Hospitality REIT’s recent 19.43% 1 month share price return and 15.17% year to date share price return contrast with a steadier 1...
NasdaqGM:ZLAB
NasdaqGM:ZLABBiotechs

Zai Lab Weighs New Pipeline Data And KarXT Launch Against Revenue Pressures

Zai Lab (NasdaqGM:ZLAB) reported new clinical data from its global oncology and immunology pipeline, including intracranial response data for zoci in small cell lung cancer. The company is preparing to launch KarXT in China for schizophrenia in the next quarter. Management highlighted these pipeline and launch updates while also flagging near term revenue pressure. Zai Lab focuses on developing and commercializing medicines in oncology and immunology, as well as central nervous system...
NYSE:CRM
NYSE:CRMSoftware

A Look At Salesforce’s Valuation After New Agentforce AI Launches And Reporting Changes

Salesforce (CRM) is back in focus after a flurry of AI-centered announcements, including the launch of Agentforce Operations and Merck Animal Health’s decision to deploy Agentforce Life Sciences across its global customer engagement. See our latest analysis for Salesforce. Despite the flurry of AI product launches and partnerships, including Merck Animal Health adopting Agentforce Life Sciences, Salesforce’s recent price action tells a mixed story, with a 1-day share price return of 2.84% and...
OTCPK:NASB
OTCPK:NASBBanks

Strong Q2 EPS At NASB Financial (OTCPK:NASB) Tests Long Term Bearish Narratives

NASB Financial (NASB) has put up a clean set of Q2 2026 numbers, with revenue of US$24.2 million and EPS of US$1.30 anchoring the latest report. The company has seen revenue move from US$19.9 million and EPS of US$0.80 in Q2 2025 to US$24.2 million and EPS of US$1.30 in Q2 2026, while trailing twelve month EPS sits at US$4.52 on revenue of US$92.3 million. For investors, the key takeaway is that profitability and margins sit firmly at the center of this update, setting the tone for how the...
NYSE:EQR
NYSE:EQRResidential REITs

Is Equity Residential (EQR) Pricing Look Attractive After Recent 30 Day Share Price Rebound

If you are wondering whether Equity Residential at around US$65.86 offers good value today, it helps to look past the headline share price and focus on what different valuation methods are signaling. The stock has returned 0.7% over the past week and 9.4% over the last 30 days, while the 1 year return of 1.2% decline contrasts with gains of 6.2% year to date, 18.6% over 3 years and 8.3% over 5 years. Recent coverage around Equity Residential has centered on its position within the US...
NasdaqCM:MBIN
NasdaqCM:MBINDiversified Financial

Assessing Merchants Bancorp (MBIN) Valuation After Legal Probes Into Deposit Disclosures And Q1 2026 Funding Costs

Multiple law firms are scrutinizing Merchants Bancorp (MBIN) after Q1 2026 results highlighted a sharp reduction in brokered deposits and higher funding costs, raising fresh questions about the sustainability of the current earnings profile. See our latest analysis for Merchants Bancorp. The stock has been volatile around Q1 2026, with a reported 9.3% single session drop after the earnings release and legal investigations. However, a 41.02% year to date share price return and 50.41% 1 year...
NYSE:SPNT
NYSE:SPNTInsurance

Assessing SiriusPoint (SPNT) After A Strong Quarter Of Growth And Capital Returns

Why SiriusPoint’s latest quarter caught investor attention SiriusPoint (SPNT) put up a busier first quarter, with higher revenue and net income, its strongest core combined ratio in six quarters, and operating return on equity at the top of its target range. See our latest analysis for SiriusPoint. The latest results appear to have kept positive momentum intact, with the share price at US$23.49 and a 90 day share price return of 12.99%, while the three year total shareholder return of 135.84%...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Is It Time To Reassess Bruker (BRKR) After Its Recent Share Price Jump?

If you are wondering whether Bruker stock is priced attractively or already reflects its prospects, the recent share moves make that question especially timely. The stock last closed at US$43.73, with returns of 19.1% over the past week and 19.3% over the past month, compared with an 8.5% gain over the past year and longer term returns over 3 and 5 years that have been negative. These shorter term gains come after a period where investors have been reassessing many life sciences and tools...
NYSE:ETSY
NYSE:ETSYMultiline Retail

Etsy (ETSY) Valuation Check After Profit Rebound And Human Centric Marketplace Shift

Q1 earnings and business shift put Etsy in focus Etsy (ETSY) is back on investors’ radar after first quarter 2026 results showed revenue of US$631.28 million and net income of US$69.68 million, compared with a loss a year earlier. The company also highlighted a push toward more human centric buyer and seller interactions, which it links to higher engagement and early momentum in key metrics across its marketplaces. See our latest analysis for Etsy. The 1 month share price return of 18.69% and...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

A Look At Recursion Pharmaceuticals (RXRX) Valuation After Recent Clinical And Cost Management Updates

Recursion Pharmaceuticals (RXRX) is back in focus after a busy Q1 2026, with fresh clinical data for REC-1245, first patient dosing for REC-4539, and FDA engagement around REC-4881 following promising Phase 2 results. See our latest analysis for Recursion Pharmaceuticals. The clinical updates and Q1 results have come with pressure on the stock, with a 30 day share price return of 2.51% contrasting with a 1 year total shareholder return decline of 25.51%, which points to fading longer term...
NasdaqGS:PDD
NasdaqGS:PDDMultiline Retail

Is PDD’s Upgraded Earnings Outlook and Global Push Altering The Investment Case For PDD Holdings (PDD)?

In early May 2026, PDD Holdings drew heightened attention as analysts highlighted expectations for a significant year-over-year earnings increase ahead of its 19 May Q1 2026 results, supported by an upgrade from Arete and reiterated positive views from other research firms. Analysts pointed to PDD Holdings' strengthening earnings outlook, international expansion focus, and supply chain improvements as key reasons for their more optimistic stance on the business. We'll now examine how this...
NYSE:IP
NYSE:IPPackaging

International Paper (IP) Valuation Check As Q1 2026 Profit Returns But Cost And Demand Headwinds Persist

International Paper (IP) is back in focus after Q1 2026 earnings showed higher sales and a shift from loss to profit, even as management highlighted margin pressure, cost inflation, and softer packaging demand. See our latest analysis for International Paper. International Paper's share price has been under pressure, with a 90 day share price return of 28.98% and a year to date share price return of a 17.81% decline. The 3 year total shareholder return of 19.41% contrasts with the 23.24%...
NYSE:A
NYSE:ALife Sciences

Is Agilent Technologies (A) Fairly Priced After Mixed Returns And DCF Upside Signals?

Wondering if Agilent Technologies at US$118.65 is offering solid value or just fair pricing right now? This article breaks down what the current market price might be implying. The stock is up 2.7% over the last week and 4.2% over the last month, even though the year to date return stands at a 14.0% decline and the 1 year return is 10.0%. Taken together, these figures provide a mixed picture of sentiment and recent momentum. Recent coverage has focused on how Agilent Technologies fits into...
NYSE:BKSY
NYSE:BKSYProfessional Services

A Look At BlackSky Technology (BKSY) Valuation After Raised 2026 Guidance And New US$99 Million Contract

BlackSky Technology (BKSY) is back in focus after raising its 2026 revenue and adjusted EBITDA guidance, supported by fully commissioned Gen-3 satellites, a US$99 million Air Force Research Lab contract, and growing subscription demand. See our latest analysis for BlackSky Technology. The sharp 20.4% one day share price decline to US$32.24 came after weaker first quarter results, even as BlackSky highlighted rising demand for Gen-3 subscriptions, a stronger backlog and higher 2026 guidance...
NasdaqGS:ZD
NasdaqGS:ZDInteractive Media and Services

Ziff Davis (ZD) One Off Loss Pressures Margins And Tests Bullish Earnings Growth Narrative

Ziff Davis (ZD) has just wrapped up FY 2025 with fourth quarter revenue of US$406.7 million and basic EPS of roughly US$0.01. Trailing 12 month revenue came in at about US$1.5 billion with basic EPS of US$1.16. Over recent periods, revenue has moved from US$412.8 million in Q4 2024 to US$406.7 million in Q4 2025, and quarterly EPS has ranged from a loss of about US$0.09 in Q3 2025 to US$0.63 in Q2 2025. This sets up a results snapshot where investors are weighing modest profitability against...
NYSE:KLAR
NYSE:KLARDiversified Financial

Klarna Probe Puts IPO Disclosures And Loan Loss Reserves Under Spotlight

Investors in Klarna Group (NYSE:KLAR) are facing an investigation into potential breaches of fiduciary duty by the company’s directors and officers. The probe focuses on allegations that Klarna’s IPO registration included misleading statements about its loan loss reserves. The investigation is linked to a recently announced lawsuit challenging the accuracy and completeness of those disclosures. Klarna Group, listed on the NYSE under the ticker NYSE:KLAR, is trading at $14.72, with the stock...
NYSE:COUR
NYSE:COURConsumer Services

Coursera (COUR) Valuation Check After Recent Share Price Rebound And Ongoing Profitability Challenges

Stock performance snapshot Coursera (COUR) has drawn investor attention after recent trading, with the stock closing at US$6.27 and showing mixed total returns across different periods, including the past month, past 3 months, year to date, and over longer horizons. See our latest analysis for Coursera. Recent trading has lifted Coursera’s short term momentum, with a 1-day share price return of 3.98% and a 90-day share price return of 6.09%. However, this sits against a year to date share...
NYSE:WCN
NYSE:WCNCommercial Services

Is Waste Connections (WCN) Now Attractive After a 20.8% Share Price Slide?

For investors considering whether Waste Connections at around US$153.57 represents fair value or a potential opportunity, this article explains what the current price may indicate. The stock has come under recent pressure, with a 6.8% decline over the last week, a 6.4% decline over the last month, and a 20.8% decline over the last year. This comes despite 3 year and 5 year returns of 9.3% and 32.4% respectively. Recent coverage has examined how the stock's pullback compares with the broader...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

Akamai’s US$1.8b AI Deal Reshapes Growth, Cloud And Valuation Story

Akamai Technologies (NasdaqGS:AKAM) has secured a seven year, US$1.8b cloud services contract with a major frontier AI model provider. The agreement is Akamai's largest cloud services deal to date and follows the company's recent Q1 results. The deal comes alongside product developments in API security aimed at supporting emerging AI workloads. Akamai sits at the intersection of content delivery, security and cloud infrastructure, and this new agreement puts that mix directly in front of a...
NYSE:WTTR
NYSE:WTTREnergy Services

Will Steady EPS and Paused Buybacks Reframe Select Water Solutions' (WTTR) Capital Allocation Narrative?

Select Water Solutions, Inc. has reported past first-quarter 2026 results, with sales of US$96.74 million, revenue of US$365.96 million, and net income of US$8.61 million, while leaving basic and diluted earnings per share from continuing operations unchanged at US$0.08. The company also reported no share repurchases in the quarter, even though it has previously completed buybacks totaling more than 13.28 million shares across multiple authorizations, which could influence how investors...
NasdaqGS:DGII
NasdaqGS:DGIICommunications

Digi International Reshapes IoT Model As ARR Jumps 50%

Digi International acquired Jolt Software and Particle Industries, reshaping its Internet of Things (IoT) offering. The company reports that these deals, combined with organic growth, have lifted annual recurring revenue (ARR) by 50%. Management highlights strong cash flow as a key support for integrating these acquisitions into the existing business. Digi International (NasdaqGS:DGII) is drawing fresh attention as it leans harder into IoT platforms and recurring software revenue. The stock...
NasdaqGS:ACT
NasdaqGS:ACTDiversified Financial

How Enact’s Dividend Hike and Q1 2026 Profitability Will Impact Enact Holdings (ACT) Investors

Enact Holdings, Inc. recently reported first-quarter 2026 results, with revenue of US$312.07 million and net income of US$167.77 million, and announced a quarterly dividend of US$0.24 per share payable on June 18, 2026. The combination of slightly higher earnings and a 14% dividend increase highlights management’s emphasis on returning capital while maintaining disciplined mortgage insurance operations. Next, we’ll examine how Enact’s dividend increase and solid first-quarter profitability...